These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23206977)

  • 21. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone and atherosclerosis.
    Ichiki T
    Vascul Pharmacol; 2010; 52(3-4):151-6. PubMed ID: 19808101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia.
    Östlund E; Al-Nashi M; Hamad RR; Larsson A; Eriksson M; Bremme K; Kahan T
    Hypertens Res; 2013 Dec; 36(12):1081-7. PubMed ID: 23945964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of thyroid dysfunction with cardiovascular diseases: updated review on heart failure progression.
    Abdel-Moneim A; Gaber AM; Gouda S; Osama A; Othman SI; Allam G
    Hormones (Athens); 2020 Sep; 19(3):301-309. PubMed ID: 32488814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between thyroid and kidney function in pathological conditions of these organ systems: a review.
    van Hoek I; Daminet S
    Gen Comp Endocrinol; 2009 Feb; 160(3):205-15. PubMed ID: 19133263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progenitor cells and vascular function are impaired in patients with chronic kidney disease.
    Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC
    Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular issues in dialysis patients: challenges and newer insights.
    Guzon OJ; Dellsperger KC
    Adv Perit Dial; 2006; 22():111-5. PubMed ID: 16983952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormones and the cardiovascular system: pathophysiology and interventions.
    Cini G; Carpi A; Mechanick J; Cini L; Camici M; Galetta F; Giardino R; Russo MA; Iervasi G
    Biomed Pharmacother; 2009 Dec; 63(10):742-53. PubMed ID: 19917524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between some of the cardiovascular risk factors and arterial stiffness parameters in essentially hypertensive patients.
    Altun B; Bulucu F; Demirbas S; Karaman M; Ay SA; Cakar M; Apikoglu M; Saglam K; Demirkol S; Balta S
    Clin Exp Hypertens; 2013; 35(6):444-8. PubMed ID: 23194388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid disease and vascular function.
    Owen PJ; Sabit R; Lazarus JH
    Thyroid; 2007 Jun; 17(6):519-24. PubMed ID: 17614771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The renal manifestations of thyroid disease.
    Mariani LH; Berns JS
    J Am Soc Nephrol; 2012 Jan; 23(1):22-6. PubMed ID: 22021708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiposopathy and thyroid disease: tracing the pathway to cardiovascular risk.
    Duntas L; Micic D
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):797-803. PubMed ID: 22894634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH; Brenta G
    Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular stiffening and endothelial dysfunction in atherosclerosis.
    Hooglugt A; Klatt O; Huveneers S
    Curr Opin Lipidol; 2022 Dec; 33(6):353-363. PubMed ID: 36206080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of continuous positive airway pressure therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized controlled trial in patients without cardiovascular disease.
    Jones A; Vennelle M; Connell M; McKillop G; Newby DE; Douglas NJ; Riha RL
    Sleep Med; 2013 Dec; 14(12):1260-5. PubMed ID: 24210600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid hormone and blood pressure regulation.
    Danzi S; Klein I
    Curr Hypertens Rep; 2003 Dec; 5(6):513-20. PubMed ID: 14594573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients.
    Sun W; Liu D; Gong P; Shi X; Wang Y; Wang P; Gong W
    Ann Transplant; 2014 Oct; 19():513-8. PubMed ID: 25315215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.